We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
MSC Industrial Direct
MSM
$6.86B
| $9.52M | ﹤0.01% |
116,546
-2,917
| -2% | -$238K |
|
1502
Globalstar
GSAT
$10.8B
| $9.49M | ﹤0.01% |
475,549
-123,425
| -21% | -$3.24M |
|
|
RYZ
1503
Ryerson Holding Corp
RYZ
$1.46B
| $9.49M | ﹤0.01% |
313,505
-21,316
| -6% | -$632K |
|
1504
Laureate Education
LAUR
$5.28B
| $9.44M | ﹤0.01% |
981,183
+235,215
| +32% | +$2.54M |
|
|
COWN
1505
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $9.43M | ﹤0.01% |
244,218
-160,101
| -40% | -$6.19M |
|
|
GAP
1506
The Gap Inc
GAP
$7.37B
| $9.43M | ﹤0.01% |
835,748
+1,534
| +0.2% | +$18.4K |
|
1507
John B. Sanfilippo & Son
JBSS
$972M
| $9.42M | ﹤0.01% |
115,786
-4,600
| -4% | -$375K |
|
1508
StoneX
SNEX
$7.94B
| $9.41M | ﹤0.01% |
499,714
+52,255
| +12% | +$967K |
|
1509
Axsome Therapeutics
AXSM
$10.9B
| $9.41M | ﹤0.01% |
121,945
-571,579
| -82% | -$34.2M |
|
1510
BOK Financial
BOKF
$8.74B
| $9.4M | ﹤0.01% |
90,617
-717
| -0.8% | -$72.7K |
|
1511
Outset Medical
OM
$90.8M
| $9.4M | ﹤0.01% |
24,271
+15,283
| +170% | +$4.31M |
|
1512
Boston Beer
SAM
$1.92B
| $9.35M | ﹤0.01% |
28,376
-95
| -0.3% | -$34.5K |
|
1513
Timken Company
TKR
$9.03B
| $9.35M | ﹤0.01% |
132,249
-165
| -0.1% | -$11.5K |
|
1514
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
| $9.34M | ﹤0.01% |
151,022
-85,755
| -36% | -$5.43M |
|
1515
Deluxe
DLX
$1.15B
| $9.32M | ﹤0.01% |
548,944
-50,944
| -8% | -$906K |
|
1516
Pricesmart
PSMT
$5.46B
| $9.3M | ﹤0.01% |
153,101
-3,743
| -2% | -$244K |
|
|
LSXMA
1517
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $9.29M | ﹤0.01% |
321,717
+53,335
| +20% | +$1.63M |
|
1518
Myers Industries
MYE
$1.29B
| $9.29M | ﹤0.01% |
417,774
+38,975
| +10% | +$810K |
|
1519
Hawaiian Electric Industries
HE
$2.14B
| $9.26M | ﹤0.01% |
221,348
-7,881
| -3% | -$304K |
|
|
RVNC
1520
DELISTED
Revance Therapeutics, Inc.
RVNC
| $9.24M | ﹤0.01% |
500,847
-118,317
| -19% | -$2.71M |
|
|
SILK
1521
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $9.24M | ﹤0.01% |
174,803
+75,911
| +77% | +$3.7M |
|
1522
Enact Holdings
ACT
$6.73B
| $9.23M | ﹤0.01% |
382,496
+23,273
| +6% | +$568K |
|
1523
Claros Mortgage Trust
CMTG
$274M
| $9.21M | ﹤0.01% |
626,199
+99,354
| +19% | +$1.56M |
|
1524
Tencent Music
TME
$15.6B
| $9.19M | ﹤0.01% |
1,110,097
-44,100
| -4% | -$248K |
|
1525
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $9.16M | ﹤0.01% |
293,859
+92,949
| +46% | +$2.96M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.